Merry Christmas and Happy New Year from Direct Peptides
We’ll be CLOSED on 25th, 26th December, and 1st January. Half-day openings on 27th and 31st December. Back to normal hours on 2nd January. Happy Holidays!

Leaders in Research Peptides

(£) GBP (Default)
  • ($) USD
  • (€) EUR
  • ($) AUD
  • ($) CAD
  • ($) NZD
(£) GBP (Default)
  • ($) USD
  • (€) EUR
  • ($) AUD
  • ($) CAD
  • ($) NZD

HGH Fragment CJC-1295 Dac Pre Mixed 2.5mg

£21.08£63.88

The HGH Fragment CJC-1295 DAC Pre Mixed 2.5mg Blend is a potent combination of synthetic peptides designed to amplify the body’s natural growth hormone (GH) production.

HGH Fragment 176-191 = 1.7mg | CJC 1295 = 0.8mg

Pre Mixed Cartridge and Kit:

  • 1 x Cartridge (The cartridge is premixed with the peptide vial of your choice and Bacteriostatic Water)
  • 1 x Peptide Cartridge Pen
  • 1 x Pen Carry Case
  • 3 x Pen Needle Tips

Single Mixed Cartridges (1,2 & 3) Come with:

  • 1,2 or 3 x Cartridge (The cartridge is premixed with the peptide vial of your choice and Bacteriostatic Water)
  • 3 x Pen Needle Tips

The single 1,2 & 3 cartridges do not come with a kit. Save 10% when buying 3 cartridges.

Buy 10 and get 10% Discount

426 in stock

Description

Buy HGH Fragment CJC-1295 DAC Pre Mixed 2.5mg Blend New Zealand

This product is intended for research purposes only. To be used by trained professionals only.

The HGH Fragment CJC-1295 DAC Pre Mixed 2.5mg Blend is a sophisticated formulation designed to optimise growth hormone release and enhance anabolic processes while minimising unwanted side effects.

This pre-mixed blend combines HGH Fragment, a modified form of human growth hormone that emphasises lipolysis and fat reduction, with CJC-1295 DAC (Drug Affinity Complex), which prolongs the action of growth hormone by enhancing its half-life.

This synergy allows for an effective approach to body composition management, promoting fat loss alongside the preservation of lean muscle mass. The 2.5mg dosage simplifies administration and ensures accurate dosing, making it particularly valuable for research institutes focused on performance enhancement, metabolic regulation, and the physiological impacts of growth hormone therapy.

This blend represents a significant advancement in the exploration of targeted anabolic effects and recovery optimisation within sports science and clinical endocrinology research.

For an in-depth exploration of these peptides, including their mechanisms of action, benefits, potential side effects, and the variety of products offered by Direct Peptides New Zealand, refer to the appropriate category pages.


Key Features of HGH Fragment CJC-1295 DAC Pre Mixed 5mg Blend

  • Optimised Growth Hormone Release: Formulated to enhance the release of growth hormone effectively while reducing undesirable side effects.
  • Combined Anabolic Action: Merges the properties of HGH Fragment for fat loss and CJC-1295 DAC for extended growth hormone half-life, targeting body composition improvements.
  • Preservation of Lean Muscle Mass: Supports the retention of muscle while facilitating fat reduction, making it ideal for athletes and those focused on body composition.
  • Simple Administration: The pre-mixed formulation offers convenience and ensures accurate dosing without the need for reconstitution.
  • Research-Focused Dosage: The 2.5mg dosing is tailored for research applications, ensuring consistency and reliability in studies.
  • Versatile Applications: Suitable for exploring a range of scientific inquiries related to performance enhancement and metabolic health.
  • Advanced Synergistic Effects: Leverages the combined action of its components to maximize the anabolic benefits for users.

 

Explore our wide range of pre-mixed peptide pens for research at Direct Peptides New Zealand. You can also view our extensive research supplies here.


References:

[1] M Heffernan, R J Summers, A Thorburn, E Ogru, R Gianello, W J Jiang, F M Ng (2001) The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice – Endocrinology, 2001 Dec, Volume 142 (Issue 12), Pages 5182-9.

[2] S L Teichman, A Neale, B Lawrence, C Gagnon, JP Castaigne, L A Frohman (2006) Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults – Journal of Clinical Endocrinology and Metabolism, 2006 Mar, Volume 91 (Issue 3), Pages 799-805.


ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.

DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our New Zealand Direct Peptides website: https://new-zealand.direct-peptides.com is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.


BUY HGH Fragment CJC-1295 DAC Pre Mixed 2.5mg Peptide Blend ONLINE today From Direct Peptides

You may also like…